美敦力(MDT)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 MDT 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement FY 2026
Item	Category	Value	YoY
Net sales	revenue	36.36B	8.43%
Other non-operating expense (income), net	revenue	384.00M	-4.48%
Reportable segment operating profit	profit	6.47B	8.60%
Cost of products sold, excluding amortization of intangible assets	cost	12.72B	9.36%
Selling, general, and administrative expense	cost	11.78B	8.62%
Research and development expense	cost	2.87B	5.16%
Amortization of intangible assets	cost	1.77B	-1.94%
Other operating income (expense), net	revenue	386.00M	-17.78%
Restructuring charges, net	cost	249.00M	-6.74%
Certain litigation charges, net	cost	113.00M	-64.35%
Aggregate	revenue	6.85B	7.77%
Income before income taxes	profit	6.14B	9.03%
Interest expense, net	cost	715.00M	-1.92%
Net income	profit	4.84B	3.11%
Income tax provision	cost	1.30B	38.78%
Net income attributable to medtronic	profit	4.80B	2.98%
Net income (loss) attributable to noncontrolling interest	cost	37.00M	27.59%

Business Breakdown
Segment	Value	YoY
Cardiovascular	13.98B	11.98%
Neuroscience Group	10.29B	4.48%
Medical Surgical	8.81B	4.85%
Diabetes Group	3.11B	12.96%
Other Operating Segment, Misc	135.00M	-1.46%
Others	39.00M

Geography Breakdown
Segment	Value	YoY
Total Other Countries, Excluding United States and Ireland	18.12B	11.50%
UNITED STATES	18.10B	5.43%
IRELAND	143.00M	23.28%

Balance Sheet FY 2026
Item	Category	Value	YoY
Investments	assets	7.27B	7.77%
Accounts receivable, less allowance for credit losses of $190 and $199, respectively	assets	6.64B	1.96%
Inventories	assets	5.95B	8.67%
Other current assets	assets	2.97B	3.99%
Cash and cash equivalents	assets	1.95B	-12.13%
Total current assets	assets	24.79B	4.09%
Goodwill	assets	42.59B	2.04%
Other intangible assets, net	assets	10.15B	-13.04%
Property, plant, and equipment, net	assets	7.42B	8.48%
Other assets	assets	4.15B	15.71%
Tax assets	assets	3.94B	-2.40%
Total assets	assets	93.03B	1.47%
Total equity	liabilities	50.07B	3.76%
Total liabilities	liabilities	42.96B	-1.08%
Noncontrolling interests	liabilities	609.00M	162.50%
Accumulated other comprehensive loss	equity	4.10B	-4.27%
Total shareholders’ equity	equity	49.46B	3.00%
Long-term debt	liabilities	26.17B	2.07%
Total current liabilities	liabilities	11.66B	-9.48%
Other liabilities	liabilities	2.06B	16.17%
Accrued income taxes	liabilities	1.51B	-3.75%
Accrued compensation and retirement benefits	liabilities	1.19B	3.02%
Deferred tax liabilities	liabilities	362.00M	-10.17%
Aggregate	equity	53.56B	2.40%
Other accrued expenses	liabilities	3.63B	-1.33%
Accrued compensation	liabilities	2.68B	6.52%
Accounts payable	liabilities	2.64B	7.96%
Current debt obligations	liabilities	1.79B	-37.79%
Accrued income taxes	liabilities	914.00M	-32.70%
Retained earnings	equity	32.64B	3.69%
Additional paid-in capital	equity	20.93B	0.45%

Operating Activities – 12M 2026
Item	Value
Net income	4.84B
Depreciation and amortization	2.96B
Stock-based compensation	457.00M
Other noncash income (expense)	314.00M
Provision for credit losses	136.00M
Deferred income taxes	51.00M
Accounts payable and accrued liabilities	46.00M
Increase (decrease) in accounts and notes receivable	-200.00M
Increase (decrease) in inventories	-404.00M
Increase (decrease) in other operating assets and liabilities, net	-865.00M

Investing Activities – 12M 2026
Item	Value
Sales and maturities of investments	8.11B
Payment for (proceeds from) other investing activity	-4.00M
Payments to acquire businesses, net of cash acquired	-406.00M
Payments to acquire property, plant, and equipment	-1.90B
Payments to acquire investments	-8.72B

Financing Activities – 12M 2026
Item	Value
Issuance of long-term debt	1.75B
Proceeds from minimed initial public offering	538.00M
Issuance of ordinary shares	516.00M
Other financing activities, net	44.00M
Change in current debt obligations, net	9.00M
Payments for repurchase of common stock	-1.03B
Repayments of long-term debt	-2.93B
Payments of ordinary dividends, common stock	-3.64B

Cash Balance – 12M 2026
Item	Value
Cash and cash equivalents, beginning of period	2.22B
Cash and cash equivalents, end of period	1.95B